Nieuws
MIT COVID-19 Challenge; Sequel in The Netherlands
On Friday the 12th of June, a couple of international teams that joined the MIT COVID-19 Challenge at the beginning of April had the opportunity to pitch their solutions against COVID-19 to a group of Dutch stakeholders from the Life Sciences & Health community to explore possibilities to implement their solution in the Netherlands.
Sirius Medical Announces CE Mark for Pintuition: to Improve Breast Cancer Surgery
Sirius Medical, a MedTech startup, announced that it has received CE mark approval for Sirius Pintuition. With its debut product, Sirius provides an affordable and easy-to-use alternative to traditional surgical localisation systems that rely on anchor wires or radioactive seeds. Sirius aims to revolutionise the way tumors are localised during surgery.
Johnson & Johnson Announces Acceleration of its COVID-19 Vaccine Candidate
Johnson & Johnson announced that through its Janssen Pharmaceutical Companies (Janssen) it has accelerated the initiation of the Phase 1/2a first-in-human clinical trial of its investigational SARS-CoV-2 vaccine, Ad26.COV2-S, recombinant. Initially scheduled to begin in September, the trial is now expected to commence in the second half of July.
Annual Report 2019 of Regieorgaan SIA
Het jaar 2019 was een goed jaar voor het praktijkgerichte onderzoek en Regieorgaan SIA. Ze verkenden de toekomst van het praktijkgerichte onderzoek, reikten de eerste Deltapremies uit en ondertekenden met NWO het Kennis en Innovatieconvenant 2020-2023.
News article 2
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur congue mollis risus, imperdiet mollis velit convallis eu. Cras dui lorem, scelerisque at felis quis, convallis sodales ante.
Kite Receives European Medicines Agency Approval for CAR T Cell Therapy Manufacturing Facility in Europe
Kite, a Gilead Company (Nasdaq: GILD), announced it has received approval to implement a variation to the Yescarta® (axicabtagene ciloleucel) Marketing Authorization from the European Medicine Agency (EMA) for end-to-end manufacturing. With this approval, Kite’s European manufacturing facility, designed and dedicated to the manufacture of individualised cell therapies, is now fully operational.
Six More Projects Awarded in COVID-19 Call
Since the foundation of Top Sector LSH, it has supported numerous projects with research into coronaviruses. At the end of March, Health~Holland set up a call for COVID-19 related research proposals. In May we announced that in only one month four projects were awarded by the Health~Holland board. This week we announce the good news that six more projects have been granted PPP Allowance to start their research.
National Healthcare Innovation Award Winners Are TrueSim and Wolkheupairbag
Op het LSH010 ontbijt zijn de winnaars van de Nationale Zorginnovatieprijs 2020 bekend gemaakt. TrueSim en Wolk Heupairbag zijn uitgeroepen tot winnaars. TrueSim ontving de vakjury prijs van €10.000,- en het publiek koos voor Wolk Heupairbag als winnaar van de €5.000,- publieksprijs.
LUMC Involved in the Development of New Drugs Against SARS-CoV-2 and Other Coronaviruses
De afdeling Medische Microbiologie van het Leids Universitair Medisch Centrum (LUMC) doet binnen diverse projecten onderzoek naar antivirale middelen tegen SARS-CoV-2. Als onderdeel van het PanCoroNed project wordt onder leiding van dr. Martijn van Hemert in het laboratorium de antivirale werking getest van moleculen die in Nijmegen ontwikkeld worden.
Horizon Scan Clarifies the Innovative Power of the Pharmaceutical Sector
Het aantal nieuwe innovatieve geneesmiddelen die de komende tijd beschikbaar komen, is weer toegenomen. Ook het vinden van een middel tegen COVID-19 heeft de hoogste prioriteit. Dat blijkt uit de Horizonscan van Zorginstituut Nederland.